354 related articles for article (PubMed ID: 14999689)
1. Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress.
Serviddio G; Pereda J; Pallardó FV; Carretero J; Borras C; Cutrin J; Vendemiale G; Poli G; Viña J; Sastre J
Hepatology; 2004 Mar; 39(3):711-20. PubMed ID: 14999689
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants.
Mitsuyoshi H; Nakashima T; Sumida Y; Yoh T; Nakajima Y; Ishikawa H; Inaba K; Sakamoto Y; Okanoue T; Kashima K
Biochem Biophys Res Commun; 1999 Sep; 263(2):537-42. PubMed ID: 10491327
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of ursodeoxycholic acid on liver mitochondrial function in rats with alloxan-induced diabetes: link with oxidative stress.
Lukivskaya O; Patsenker E; Buko VU
Life Sci; 2007 Jun; 80(26):2397-402. PubMed ID: 17512017
[TBL] [Abstract][Full Text] [Related]
4. Maternal cholestasis induces placental oxidative stress and apoptosis. Protective effect of ursodeoxycholic acid.
Perez MJ; Macias RI; Marin JJ
Placenta; 2006 Jan; 27(1):34-41. PubMed ID: 16310035
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.
Perez MJ; Macias RI; Duran C; Monte MJ; Gonzalez-Buitrago JM; Marin JJ
J Hepatol; 2005 Aug; 43(2):324-32. PubMed ID: 15970352
[TBL] [Abstract][Full Text] [Related]
6. Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placental-fetal unit in cholestasis during pregnancy.
Perez MJ; Castaño B; Jimenez S; Serrano MA; Gonzalez-Buitrago JM; Marin JJ
Toxicol Appl Pharmacol; 2008 Oct; 232(2):327-36. PubMed ID: 18706437
[TBL] [Abstract][Full Text] [Related]
7. A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis.
Serviddio G; Bellanti F; Giudetti AM; Gnoni GV; Petrella A; Tamborra R; Romano AD; Rollo T; Vendemiale G; Altomare E
J Pharmacol Exp Ther; 2010 Mar; 332(3):922-32. PubMed ID: 20008062
[TBL] [Abstract][Full Text] [Related]
8. Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver.
Macias RI; Jimenez S; Serrano MA; Monte MJ; Marin JJ
Life Sci; 2006 Aug; 79(10):1014-9. PubMed ID: 16764892
[TBL] [Abstract][Full Text] [Related]
9. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
Yang YY; Huang YT; Lee KC; Lee FY; Lee TY; Hou MC; Lin HC; Lee SD
Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.
Santos NA; Catão CS; Martins NM; Curti C; Bianchi ML; Santos AC
Arch Toxicol; 2007 Jul; 81(7):495-504. PubMed ID: 17216432
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine alterations in experimental cholestasis and its subsequent cirrhosis.
Ebrahimkhani MR; Sadeghipour H; Dehghani M; Kiani S; Payabvash S; Riazi K; Honar H; Pasalar P; Mirazi N; Amanlou M; Farsam H; Dehpour AR
Life Sci; 2005 Apr; 76(21):2497-512. PubMed ID: 15763080
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
Paumgartner G; Beuers U
Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis.
Lukivskaya O; Zavodnik L; Knas M; Buko V
Adv Med Sci; 2006; 51():54-9. PubMed ID: 17357278
[TBL] [Abstract][Full Text] [Related]
15. Elevation of mitochondrial glutathione by gamma-glutamylcysteine ethyl ester protects mitochondria against peroxynitrite-induced oxidative stress.
Drake J; Sultana R; Aksenova M; Calabrese V; Butterfield DA
J Neurosci Res; 2003 Dec; 74(6):917-27. PubMed ID: 14648597
[TBL] [Abstract][Full Text] [Related]
16. Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis.
Jou MJ; Peng TI; Yu PZ; Jou SB; Reiter RJ; Chen JY; Wu HY; Chen CC; Hsu LF
J Pineal Res; 2007 Nov; 43(4):389-403. PubMed ID: 17910608
[TBL] [Abstract][Full Text] [Related]
17. Silybin exerts antioxidant effects and induces mitochondrial biogenesis in liver of rat with secondary biliary cirrhosis.
Serviddio G; Bellanti F; Stanca E; Lunetti P; Blonda M; Tamborra R; Siculella L; Vendemiale G; Capobianco L; Giudetti AM
Free Radic Biol Med; 2014 Aug; 73():117-26. PubMed ID: 24819445
[TBL] [Abstract][Full Text] [Related]
18. Endogenous opioids modulate hepatocyte apoptosis in a rat model of chronic cholestasis: the role of oxidative stress.
Payabvash S; Kiumehr S; Nezami BG; Zandieh A; Anvari P; Tavangar SM; Dehpour AR
Liver Int; 2007 May; 27(4):538-47. PubMed ID: 17403194
[TBL] [Abstract][Full Text] [Related]
19. Aroclor 1254 induced cytotoxicity and mitochondrial dysfunction in isolated rat hepatocytes.
Aly HA; Domènech O
Toxicology; 2009 Aug; 262(3):175-83. PubMed ID: 19486918
[TBL] [Abstract][Full Text] [Related]
20. New therapeutical indications of ursodeoxycholic acid.
Copaci I; Micu L; Iliescu L; Voiculescu M
Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
